Reshape Lifesciences (NASDAQ:RSLS) Stock, Earnings Estimates, EPS, And Revenue

Reshape Lifesciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 14
EPS
$-3.110
Quarterly Revenue
$2.3M
Annual Revenue
(as of Sep 30)
$8.2M

Analyze the earnings history of Reshape Lifesciences using advanced sorting and filters.

Data brought to you by Benzinga APIs

Reshape Lifesciences (RSLS) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Mar 20242024-05-15$-5.22$-9.2843.8 %
Sep 20232023-11-08$-59.16$-69.6015.0 %
Jun 20232023-08-07$-62.64$-103.8239.7 %
Mar 20232023-05-15$-90.48$-244.1862.9 %

Reshape Lifesciences (RSLS) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Sep 20242024-11-14$2.29M$2.51M-8.69 %
Jun 20242024-08-14$1.97M$2.21M-11.1 %
Mar 20242024-05-15$1.94M$2.10M-7.43 %
Sep 20232023-11-08$2.15M$2.40M-10.2 %

FAQ

Q

When is Reshape Lifesciences (NASDAQ:RSLS) reporting earnings?

A

Reshape Lifesciences ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Reshape Lifesciences (NASDAQ:RSLS)?

A

Reshape Lifesciences ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was $-3.11, which missed the estimate of $0.00.

Q

What were Reshape Lifesciences’s (NASDAQ:RSLS) revenues?

A

Reshape Lifesciences ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which missed the estimate of {{estEPS}}.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch